Watch stocks on Mar'22:Sun Pharma,Coal India,JP Associates

Stocks to watch on MAR'22:Sun Pharma:Drugmaker received a U.S. Food & Drug Administration approval for its psoriasis drug TildraKizumab.Coal India:State-owned miner allotted 11 mines that will increase annual output to 225 million tonnes.Jaiprakash Associates:Supreme Court has asked firm to deposit Rs 200 cr by May 10 to refund homebuyers in projects being developed by a group co.Reliance Communications:Firm recd bondholders' approval for asset monetization plan.

Here are a few stocks that are likely to move in trades on Thursday:

Sun Pharma: The drugmaker received a U.S. Food and Drug Administration approval for its novel psoriasis drug TildraKizumab.

Coal India: The state-owned miner allotted 11 mines that will increase annual output to 225 million tonnes.

Jaiprakash Associates: The Supreme Court has asked the firm to deposit Rs 200 crore by May 10 to refund homebuyers in projects being developed by a group company.

Reliance Communications: The firm has received bondholders' approval for asset monetization plan, according to a Mint report. --- Dated: Mar'22,2018.

Zensar Technologies: The company will buy Cynosure India for $33 million and Cynosure U.S. for $31 million.

Oil India: The company entered into an agreement with Assam for Methanol, Formaldehyde project.

Arvind: Adient India and the company have formed joint venture to make automotive fabric in India, Hindu BusinessLine reported.

Dilip Buildcon: The company declared lowest bidder for a new EPC project worth Rs 870 crore in Uttar Pradesh.

GE Power: The company received order worth Rs 230 crore from NTPC. Ref. : http://www.ibtimes.co.in/stocks-watch-march-22-sun-pharma-coal-india-jp-associates-764558

Similar Ripples

Questions

There is no question

Watch stocks on Mar'22:Sun Pharma,Coal India,JP Associates

Write your Comment

Would you like to edit this news ? Edit

Select Format

You get opportunity to take 30 day Challenge program.

Optional

Advanced

You get opportunity to take 30 day Challenge program.

Optional

Add tags

You get opportunity to take 30 day Challenge program.

Optional

PUBLISH IT

Don't sell
PUBLISH IT
Publish privately
SAVE AS DRAFT

Dont't publish now

Here are a few stocks that are likely to move in trades on Thursday:Sun Pharma:&nbsp;The drugmaker received a U.S. Food and Drug Administration approval for its novel psoriasis drug TildraKizumab.Coal India: The state-owned miner allotted 11 mines that will increase annual output to 225 million tonnes.Jaiprakash Associates: The Supreme Court has asked the firm to deposit Rs 200 crore by May 10 to refund homebuyers in projects being developed by a group company.Reliance Communications: The firm has received bondholders' approval for asset monetization plan, according to a Mint report. --- Dated: Mar'22,2018.Zensar Technologies: The company will buy Cynosure India for $33 million and Cynosure U.S. for $31 million.Oil India:&nbsp;The company entered into an agreement with Assam for Methanol, Formaldehyde project.Arvind: Adient India and the company have formed joint venture to make automotive fabric in India, Hindu BusinessLine reported.Dilip Buildcon:&nbsp;The company declared lowest bidder for a new EPC project worth Rs 870 crore in Uttar Pradesh.GE Power:&nbsp;The company received order worth Rs 230 crore from NTPC. Ref. : http://www.ibtimes.co.in/stocks-watch-march-22-sun-pharma-coal-india-jp-associates-764558

Here are a few stocks that are likely to move in trades on Thursday:Sun Pharma: The drugmaker received a U.S. Food and Drug Administration approval for its novel psoriasis drug TildraKizumab.Coal India: The state-owned miner allotted 11 mines that will increase annual output to 225 million tonnes.Jaiprakash Associates: The Supreme Court has asked the firm to deposit Rs 200 crore by May 10 to refund homebuyers in projects being developed by a group company.Reliance Communications: The firm has received bondholders' approval for asset monetization plan, according to a Mint report. --- Dated: Mar'22,2018.Zensar Technologies: The company will buy Cynosure India for $33 million and Cynosure U.S. for $31 million.Oil India: The company entered into an agreement with Assam for Methanol, Formaldehyde project.Arvind: Adient India and the company have formed joint venture to make automotive fabric in India, Hindu BusinessLine reported.Dilip Buildcon: The company declared lowest bidder for a new EPC project worth Rs 870 crore in Uttar Pradesh.GE Power: The company received order worth Rs 230 crore from NTPC. Ref. : http://www.ibtimes.co.in/stocks-watch-march-22-sun-pharma-coal-india-jp-associates-764558

Hi Thakurani,
I want to withdraw in my Thakurani wallet
Thanks,

Select the reason for validity check

I feel great..the news is still good.please give the reason too..thanks..

Why do you think the News as invalid?” Please mention the reason.

I appreciate your effort. May I request you to select one of the reasons from below.
I am marking this post and your reason to Thakurani Moderators. They will take appropriate action.
Thanks,

Write your reason

My Dear ,

Harassing

Spam

Ingenuine

Rotten

Alien

Plagiarism

Unformatted

Watch stocks on Mar'22:Sun Pharma,Coal India,JP Associates